Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Mansoura University | OTHER |
Not provided
Not provided
Not provided
Thoraco-laparoscopic partial esophagogastrectomy has emerged as a promising minimally invasive alternative, combining thoracoscopy and laparoscopy to reduce the trauma associated with open surgery.Early and intermediate-term outcomes provide critical information on both the oncological efficacy and functional benefits of the procedure. By examining recurrence rates within the first 12-24 months, this study will provide valuable insights into the oncological robustness of this approach compared to more invasive approaches.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Thoraco-laparoscopic partial esophagogastrectomy | Experimental | Patients diagnosed with resectable esophageal cancer will undergo thoraco-laparoscopic partial esophagogastrectomy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Thoraco-laparoscopic partial esophagogastrectomy | Procedure |
|
| Measure | Description | Time Frame |
|---|---|---|
| Immediate Postoperative complications | 30-day morbidity and mortality (using Clavien-Dindo classification) | first month post operative |
| Dysphagia | yes or no | Collected at base line preoperative,one month, and 12 months post-surgery. |
| resection margin status | resection margin status (R0/R1/R2) | 2 weeks postoperative |
| lymph node yield. | number of lymph nodes in specimen | first month post operative |
| regurgitation | yes or no | Collected at one month, and 12 months post-surgery. |
| Measure | Description | Time Frame |
|---|---|---|
| recurrence rate | first year post operative | |
| body mass index | Collected at base line preoperative,one month, and 12 months post-surgery. | |
| serum albumin |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| ahmed m salah eldin, assistant lecturer of general | Contact | +201001329315 | ahmed_mohamed2@med.sohag.edu.eg |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sohag Faculty of Medicine | Sohag | Egypt |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D004938 | Esophageal Neoplasms |
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Collected at base line preoperative,one month, and 12 months post-surgery. |
| D006258 |
| Head and Neck Neoplasms |
| D004066 | Digestive System Diseases |
| D004935 | Esophageal Diseases |
| D005767 | Gastrointestinal Diseases |